China's Sinovac Targets Long-Term Cooperation with Indonesia

According to him, Sinovac is also developing a multivariate vaccine while still using the inactive method.

The CoronaVac vaccine is claimed to be safe for use by people of all ages and at high risk.

Sinovac's production capacity at its three factories in Beijing City and Liaoning Province reaches 13 million doses of CoronaVac per day, so Meng is optimistic that they can meet the needs of Covid-19 vaccines from various countries, including Indonesia.

Since January 2021, Sinovac has distributed more than 280 million doses of vaccine to Indonesia. (ant/dil/mcr20/jpnn)

This news has been broadcast on JPNN.com with the title: Sinovac Makin Intens Dekati Indonesia, Sasar Kerja Sama Jangka Panjang